As weight drops fast, cosmetic clinics see surge in ‘Ozempic face’ fixes

Doctors expect demand for GLP-1 drugs to grow exponentially in India following the patent expiry of semaglutide. They caution that unchecked use of the drugs could lead to higher numbers.